Matthew Roden - President and CEO, Director at Aktis Oncology, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Issuer Symbol
AKTS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew Roden since 11 Mar 2025

Holdings reported by Matthew Roden for Aktis Oncology, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 91,998 08 Jan 2026 Direct

There are no transactions reported by Matthew Roden for Aktis Oncology, Inc.